Related Experiment Videos
Bayesian model selection and averaging in additive and proportional hazards models.
David B Dunson1, Amy H Herring
1Biostatistics Branch, National Institute of Environmental Health Sciences, MD A3-03, P.O. Box 12233, Research Triangle Park, NC 27709, USA. dunson1@niehs.nih.gov
Lifetime Data Analysis
|June 9, 2005
Summary
This study introduces a flexible additive-multiplicative hazards model to address uncertainty in analyzing time-to-event data. The new model allows for both additive and multiplicative effects, improving upon standard methods for survival analysis.
Area of Science:
- Biostatistics
- Survival Analysis
- Statistical Modeling
Background:
- Cox proportional hazards regression is standard for time-to-event data.
- Uncertainty exists regarding whether predictor effects are multiplicative or additive.
- Existing methods may violate non-negative hazard constraints.
Purpose of the Study:
- To develop an additive-multiplicative hazards model accommodating uncertainty in predictor effects.
- To provide a framework for selecting between additive, multiplicative, or combined effects.
- To ensure non-negative hazard rates in survival analysis.
Main Methods:
- Introduced a model selection prior on coefficients within an additive-multiplicative hazards model.
- Incorporated sub-models for no association, additive effects only, and proportional effects only.
- Utilized Poisson latent variable augmentation for conditional conjugacy.
- Employed an efficient Gibbs sampling algorithm for posterior computation.
Main Results:
- The proposed prior allows for flexible model selection, including pure additive or multiplicative effects.
- The constrained additive component ensures non-negative hazard rates.
- The Gibbs sampling algorithm provides an efficient computational approach.
Conclusions:
- The additive-multiplicative hazards model offers a robust alternative to standard Cox regression.
- This methodology enhances the analysis of time-to-event data by handling model uncertainty.
- The approach is validated through simulation studies and application to the Framingham Heart Study data.